レジオネラ検査市場レポート：用途、エンドユーザー、地域別、2025年～2033年

レジオネラ検査の世界市場規模は2024年に3億6,650万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに6億5,820万米ドルに達し、2025～2033年の成長率（CAGR）は6.66％になると予測しています。糖尿病、腎臓病、ヒト免疫不全ウイルス（HIV）、がん、その他の慢性疾患を患う人が増加しており、入院のリスクを抱えていることが市場の成長を促しています。

レジオネラ菌は下気道を侵す感染症で、重篤な肺炎、ポンティアック熱、インフルエンザのような症状を伴う病気につながる可能性があります。その検査は、血液、尿、喀痰中の細菌や抗原の存在を特定するのに役立ちます。現在、レジオネラ症の診断には、尿中抗原、ペア血清、ポリメラーゼ連鎖反応（PCR）、直接蛍光抗体（DFA）染色、下気道分泌物の培養など、さまざまな検査法が利用可能です。検査結果に応じて、マクロライド系、キノロン系、テトラサイクリン系、ドキシサイクリン系、ミノサイクリン系、トリメトプリム系などの抗生物質による治療が行われます。

世界のレジオネラ検査市場動向：

50歳以上の成人はレジオネラを発症しやすいです。その結果、世界の老人人口の増加が市場にプラスの影響を与える主要因のひとつとなっています。さらに、喫煙者、がん、糖尿病、腎臓病、ヒト免疫不全ウイルス（HIV）、その他の慢性疾患を患う人が増加しており、感染や入院のリスクがあります。レジオネラの死亡率は高いため、その効果的な診断検査や治療に対する需要が増加しています。これに加えて、レジオネラの原因菌は、冷却塔、呼吸療法装置、噴水、ミスト装置、温泉プール、ホテル、家庭、工場の水システムなど、さまざまな自然環境や人工的な水環境で主に発見されています。その結果、多くの国の保健機関は、水中でのレジオネラ菌の増殖を最小限に抑えるために、効果的な水安全計画（WSP）を策定しています。その結果、法規制を遵守するために職場の建物でレジオネラ検査を実施する需要が高まっています。さらに、市中肺炎の成人患者に対する診断および治療戦略に関する最近の臨床試験が市場の成長に寄与しています。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

• 概要
• 主要業界動向

第5章 世界のレジオネラ検査市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：用途別

• 水質検査
  • 市場動向
  • 市場内訳：タイプ別
    • 微生物培養
    • DFA染色
    • PCR
    • その他
  • 市場予測
• 体外診断検査
  • 市場動向
  • 市場内訳：タイプ別
    • 血液培養
    • 尿抗原検査
    • DFA染色
    • PCR
    • その他
  • 市場予測

第7章 市場内訳：エンドユーザー別

• 診断検査室
  • 市場動向
  • 市場予測
• 病院と診療所
  • 市場動向
  • 市場予測
• その他
  • 市場動向
  • 市場予測

第8章 市場内訳：地域別

• 欧州
  • イタリア
  • ドイツ
  • フランス
  • スペイン
  • 英国
  • ロシア
  • その他
• 北米
  • 米国
  • カナダ
• アジア太平洋地域
  • 中国
  • 日本
  • オーストラリア
  • 韓国
  • インドネシア
  • シンガポール
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
• 中東・アフリカ
  • 市場動向
  • 市場内訳：国別
  • 市場予測

第9章 SWOT分析

• 概要
• 強み
• 弱み
• 機会
• 脅威

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

• 概要
• 買い手の交渉力
• 供給企業の交渉力
• 競合の程度
• 新規参入業者の脅威
• 代替品の脅威

第12章 価格分析

第13章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • Abbott Laboratories
  • Becton, Dickinson and Company
  • BioMerieux SA
  • Bio-Rad Laboratories Inc
  • Eiken Chemical Co. Ltd
  • Quidel Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.

List of Figures

• Figure 1: Global: Legionella Testing Market: Major Drivers and Challenges
• Figure 2: Global: Legionella Testing Market: Sales Value (in Million USD), 2019-2024
• Figure 3: Global: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 4: Global: Legionella Testing Market: Breakup by Application (in %), 2024
• Figure 5: Global: Legionella Testing (Water Testing) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 6: Global: Legionella Testing Market for Water Testing: Breakup by Type (in %), 2024
• Figure 7: Global: Legionella Testing (Water Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 8: Global: Legionella Testing (IVD Testing) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 9: Global: Legionella Testing Market for IVD Testing: Breakup by Type (in %), 2024
• Figure 10: Global: Legionella Testing (IVD Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 11: Global: Legionella Testing Market: Breakup by End User (in %), 2024
• Figure 12: Global: Legionella Testing (Diagnostic Laboratory) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 13: Global: Legionella Testing (Diagnostic Laboratory) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 14: Global: Legionella Testing (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 15: Global: Legionella Testing (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 16: Global: Legionella Testing (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 17: Global: Legionella Testing (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 18: Global: Legionella Testing Market: Breakup by Region (in %), 2024
• Figure 19: Europe: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 20: Europe: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 21: Europe: Legionella Testing Market: Breakup by Country (in %), 2024
• Figure 22: Italy: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 23: Italy: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 24: Germany: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 25: Germany: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 26: France: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 27: France: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 28: Spain: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 29: Spain: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 30: United Kingdom: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 31: United Kingdom: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 32: Russia: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 33: Russia: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 34: Others: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 35: Others: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 36: North America: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 37: North America: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 38: North America: Legionella Testing Market: Breakup by Country (in %), 2024
• Figure 39: United States: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 40: United States: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 41: Canada: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 42: Canada: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 43: Asia Pacific: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 44: Asia Pacific: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 45: Asia Pacific: Legionella Testing Market: Breakup by Country (in %), 2024
• Figure 46: China: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 47: China: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 48: Japan: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 49: Japan: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 50: Australia: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 51: Australia: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 52: South Korea: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 53: South Korea: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 54: Indonesia: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 55: Indonesia: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 56: Singapore: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 57: Singapore: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 58: Others: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 59: Others: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 60: Latin America: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 61: Latin America: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 62: Latin America: Legionella Testing Market: Breakup by Country (in %), 2024
• Figure 63: Brazil: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 64: Brazil: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 65: Mexico: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 66: Mexico: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 67: Others: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 68: Others: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 69: Middle East and Africa: Legionella Testing Market: Sales Value (in Million USD), 2019 & 2024
• Figure 70: Middle East and Africa: Legionella Testing Market: Breakup by Country (in %), 2024
• Figure 71: Middle East and Africa: Legionella Testing Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 72: Global: Legionella Testing Industry: SWOT Analysis
• Figure 73: Global: Legionella Testing Industry: Value Chain Analysis
• Figure 74: Global: Legionella Testing Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Legionella Testing Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Legionella Testing Market: Breakup by Application (in Million USD), 2019 & 2024
• Table 3: Global: Legionella Testing Market Forecast: Breakup by Application (in Million USD), 2025-2033
• Table 4: Global: Legionella Testing Market: Breakup by End User (in Million USD), 2019 & 2024
• Table 5: Global: Legionella Testing Market Forecast: Breakup by End User (in Million USD), 2025-2033
• Table 6: Global: Legionella Testing Market: Breakup by Region (in Million USD), 2019 & 2024
• Table 7: Global: Legionella Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 8: Global: Legionella Testing Industry: Key Price Indicator
• Table 9: Global: Legionella Testing Market: Competitive Structure
• Table 10: Global: Legionella Testing Market: Key Players

The global legionella testing market size reached USD 366.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 658.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.66% during 2025-2033. The increasing number of individuals who have diabetes, kidney disease, human immunodeficiency virus (HIV), cancer, or other chronic illnesses, are at risk of hospitalization, which is stimulating the market growth.

Legionella is an infection affecting the lower respiratory tract, which can lead to severe pneumonia, Pontiac fever, and illness with flu-like symptoms. Its testing helps to identify the existence of bacteria or antigens in blood, urine, and sputum. Presently, various testing methods are available to diagnose Legionella disease, including urinary antigen, paired serology, Polymerase Chain Reaction (PCR), Direct Fluorescent Antibody (DFA) stain, and culture of lower respiratory secretions. As per the testing results, macrolides, quinolones, tetracycline, doxycycline, minocycline, trimethoprim and other antibiotic treatments are usually administered to patients.

Global Legionella Testing Market Trends:

Adults over the age of 50 years are more likely to develop Legionella. Consequently, the increasing geriatric population worldwide represents one of the major factors influencing the market positively. Moreover, the rising number of individuals who smoke and have cancer, diabetes, kidney disease, human immunodeficiency virus (HIV), or other chronic illnesses are at the risk of infection and hospitalization. Since the mortality rate of Legionella is high, there is an increase in the demand for its effective diagnostic tests and treatments. Besides this, Legionella-causing bacteria are majorly found in different natural and artificial aquatic environments, such as cooling towers, respiratory therapy equipment, fountains, misting devices, spa pools, and water systems in hotels, homes, and factories. As a result, health agencies of numerous countries are developing an effective water safety plan (WSP) to minimize the proliferation of Legionella in the water. This, in turn, is escalating the demand for Legionella testing in workplace buildings to comply with the legislation. Furthermore, recent clinical trials on diagnostic and treatment strategies for adult patients with community-acquired pneumonia are contributing to the growth of the market.

Legionella Testing Market Segmentation:

Breakup by Application:

Water Testing

Microbial Culture

DFA Stain

PCR

Others

IVD Testing

Blood Culture

Urine Antigen Test

DFA Stain

PCR

Others

Breakup by End User:

Diagnostic Laboratories

Hospital and Clinics

Others

Breakup by Region:

Europe

Italy

Germany

France

Spain

United Kingdom

Russia

Others

North America

United States

Canada

Asia Pacific

China

Japan

Australia

South Korea

Indonesia

Singapore

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Becton, Dickinson and Company, BioMerieux SA, Bio-Rad Laboratories Inc, Eiken Chemical Co. Ltd, Quidel Corporation, Takara Bio Inc., and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

• 1. What was the size of the global legionella testing market in 2024?
• 2. What is the expected growth rate of the global legionella testing market during 2025-2033?
• 3. What are the key factors driving the global legionella testing market?
• 4. What has been the impact of COVID-19 on the global legionella testing market?
• 5. What is the breakup of the global legionella testing market based on the application?
• 6. What is the breakup of the global legionella testing market based on the end user?
• 7. What are the key regions in the global legionella testing market?
• 8. Who are the key players/companies in the global legionella testing market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Legionella Testing Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Application

• 6.1 Water Testing
  • 6.1.1 Market Trends
  • 6.1.2 Market Breakup by Type
    • 6.1.2.1 Microbial Culture
    • 6.1.2.2 DFA Stain
    • 6.1.2.3 PCR
    • 6.1.2.4 Others
  • 6.1.3 Market Forecast
• 6.2 IVD Testing
  • 6.2.1 Market Trends
  • 6.2.2 Market Breakup by Type
    • 6.2.2.1 Blood Culture
    • 6.2.2.2 Urine Antigen Test
    • 6.2.2.3 DFA Stain
    • 6.2.2.4 PCR
    • 6.2.2.5 Others
  • 6.2.3 Market Forecast

7 Market Breakup by End User

• 7.1 Diagnostic Laboratories
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Hospital and Clinics
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Region

• 8.1 Europe
  • 8.1.1 Italy
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Germany
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
  • 8.1.3 France
    • 8.1.3.1 Market Trends
    • 8.1.3.2 Market Forecast
  • 8.1.4 Spain
    • 8.1.4.1 Market Trends
    • 8.1.4.2 Market Forecast
  • 8.1.5 United Kingdom
    • 8.1.5.1 Market Trends
    • 8.1.5.2 Market Forecast
  • 8.1.6 Russia
    • 8.1.6.1 Market Trends
    • 8.1.6.2 Market Forecast
  • 8.1.7 Others
    • 8.1.7.1 Market Trends
    • 8.1.7.2 Market Forecast
• 8.2 North America
  • 8.2.1 United States
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Canada
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
• 8.3 Asia Pacific
  • 8.3.1 China
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 Japan
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 Australia
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 South Korea
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Indonesia
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Singapore
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weakness
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porter's Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Abbott Laboratories
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 Financials
    • 13.3.1.4 SWOT Analysis
  • 13.3.2 Becton, Dickinson and Company
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
    • 13.3.2.3 Financials
    • 13.3.2.4 SWOT Analysis
  • 13.3.3 BioMerieux SA
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 Financials
    • 13.3.3.4 SWOT Analysis
  • 13.3.4 Bio-Rad Laboratories Inc
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
    • 13.3.4.4 SWOT Analysis
  • 13.3.5 Eiken Chemical Co. Ltd
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 Financials
  • 13.3.6 Quidel Corporation
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
    • 13.3.6.4 SWOT Analysis
  • 13.3.7 Takara Bio Inc.
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 inancials
  • 13.3.8 Thermo Fisher Scientific Inc.
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
    • 13.3.8.3 Financials
    • 13.3.8.4 SWOT Analysis